期刊文献+

胃癌术后割裂野单中心半野适形放疗的剂量学研究

Dosiology about 3D-conformal radiotherapy consisting of a split-field and mono-isocentric semi field technique for postoperative gastric cancer patients
原文传递
导出
摘要 目的:对比研究胃癌术后患者辅助割裂野单中心半野适形放疗(3D-SF-CRT)、三维适形放疗(3D-CRT)及前后对穿野常规放疗(AP-PA)的剂量学特点。方法:在放疗计划系统为有术后辅助放疗适应证的胃癌患者15例设计相同计划靶体积(PTV)下的3种放射治疗方案,处方剂量均为45 Gy,根据剂量体积直方图(DVH)计算并比较3种放疗方法各参数的标准差。结果:3种放疗技术的计划靶区的V95、D95差异无统计学意义(P值分别为0.521和0.241),2种适形放疗技术的适形指数差异无统计学意义(P=0.189),但均高于AP-PA,P=0.02。3D-SFCRT、3D-CRT和AP-PA的脊髓最大点剂量分别为(33.24±0.45)、(35.01±0.48)和(51.90±0.92)Gy,P=0.06。3D-SFCRT的双肾V20~V45均小于其他2种放疗技术,P〈0.05。3D-SFCRT的肝脏V25~V45比3D-CRT高,但差异均无统计学意义,P=0.261。3D-SFCRT的右肾T5/5明显低于3D-CRT,P值分别为0.001和0.008;在左肾、脊髓及肝脏,差异无统计学意义,P值均〈0.05;与AP-PA相比,3D-SF-CRT的脊髓、双肾的T5/5明显为低,P值均〈0.05;在肝脏两者类似,P=0.261。结论:胃癌术后辅助放疗,与常规适形放疗技术相比,应用割裂野单中心半野适形照射技术能在确保PTV获得满意剂量分布的同时,更好地保护脊髓及双侧肾脏,值得推广。 OBJECTIVE:To compare the features of dosiology among 3D split-field conformal radiaotherapy(3D-SFCRT),3D conformal radiaotherapy(3D-CRT) and parallelopposed anteroposterior-posteroanterior field radiaotherapy(AP-PA).METHODS: A total of 15 cases of postoperative gastric cancer patients who had indications of adjuvant radiaotherapy were involved.DVHs of 3D-SFCRT,3D-CRT and AP-PA of evrey case were separately acquired from treatment planning system(TPS).Each prescribed dose of any radiaotherapy technique was 45 Gy.Then the standard deviations of some parameters were compared among the three techniques.RESULTS: V95 and D95 about PTV had no difference among the three techniques(P=0.521;P=0.241).There was no difference of CIs between the two conformal techniques(P=0.189),but the conformal techniques had better PTV fitness than the AP-PA one(P=0.02).The maximum dose points of spinal cord in 3D-SFCRT,3D-CRT,and AP-PA were(33.24±0.45),(35.01±0.48) and(51.90±0.92) Gy,respectively,and there was a difference between any two techniques(P=0.06).V20-V45 of kidneys in 3D-SFCRT was less than that in the other two(P0.05).V25-V45 of liver was similar among the three techniques(P=0.261).T5/5 of right kidney was obviously lower in 3D-SFCRT than that in 3D-CRT(P=0.001;P=0.008),but T5/5 of spinal cord,left kidney or liver was all no difference between the two conformal methods(P0.05).Compared with AP-PA,T5/5 of 3D-SFCRT in spinal cord and kidneys,were lower(P0.05),and similar in liver(P=0.261).CONCLUSION: There are similar dose distribution of PTV,less dose of spinal cord and kidneys in 3D-SFCRT than that in 3D-CRT in gastric cancer patients that accept adjuvant postoperative randiaotherapy,therefore,3D split-field conformal radiaotherapy technique can be promoted.
出处 《中华肿瘤防治杂志》 CAS 2010年第23期1963-1966,1969,共5页 Chinese Journal of Cancer Prevention and Treatment
基金 温州市科技局科技计划项目(Y20080187)
关键词 胃肿瘤 放射疗法 适形 辐射剂量 手术后期间 stomach neoplasms radiotherapy conformal radiation dosage postoperative period
  • 相关文献

参考文献13

  • 1Macdonald J S, Smalley S R, Benedetti J, et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcino ma of the stomach or gastroesophageal junction [J]. N Engl J Med,2001,345(10) :725-730.
  • 2Chavaudra J, Bridier A. Definition of volume in external radio- therapy: ICRU reports 50 and 62[J]. Cancer Radiother, 2001, 5(5) : 472-478.
  • 3Kutcher G J,Burman C,Brewster L,et al. Histogram reduction method for calculating complication probabilities for three-dimensional treatment planning evaluations[J]. Int J Radiat Oncol Biol Phys, 1991,21(1) : 137.
  • 4Tsang W K, Leung S F, Chiu S K, Adjuvant chemoradiation for gastric cancer: experience in the Chinese population [J]. Clin Oncol (R Coll Radiol),2007,19(5):333 -340.
  • 5Tepper J E, Gunderson L L. Radiation treatment parameters in the adjuvant postoperative therapy of gastric cancer[J]. Semin Radiat Oncol, 2002,12(2) : 187-195.
  • 6Leong T, Willis D, Joon D L,et al. 3D-fonformal radiotherapy for gastric cacer results of a comparative planning study[J]. Radiother Oncol, 2005,74 (3) : 301-306.
  • 7Fabrizio P L,Mccllllougll E C,Foote R L. Decreasing the dosimetric effects of misalignment when using a mono-isocentric technique for irradiation of head and neck canser[J]. Int J Radiat Oncol Biol Phys, 2000,48 ( 5 ) : 1623-1634.
  • 8Ringash J, Khaksary S J, Oza A, et al. poat-oprative radiochemotherapy for gastric cancer :adoption and adaptation[J]. Clin On col(R Coll Radiol) ,2005,17(2) :91- 95.
  • 9Minn A Y, Hsu A, La T, et al. Comparison of intensity-modulated radiotherapy and 3 dimensional conformal radiotherapy as adjuvant therapy for gastriccancer[J]. Cancer, 2010, 116(16) 3943-3952.
  • 10熊华,陈元,邹燕梅,于世英,王俊峰.胃癌术后辅助放疗不同照射技术的剂量学对比研究[J].中华肿瘤防治杂志,2009,16(21):1686-1690. 被引量:3

二级参考文献29

  • 1Smalley S R, Gunderson L, Tepper J, et al. Gastric surgical adjuvant radiotherapy consensus report: rationale and treatment implementation[J]. Int J Radiat Oncol Biol Phys, 2002, 52(2): 283-293.
  • 2Caudry M, Ratoanina J L, Escarmant P, et al. Target volume in radiotherapy of gastric adenocarcinoma[J]. Cancer Radiother, 2001, 5(5): 523-533.
  • 3Wieland P, Dobler B, Mai S, et al. IMRT for postoperative treatment of gastric cancer: covering large target volumes in the upper abdomen: a comparison of a step-and-shoot and an arc therapy approach [J]. Int J Radiat Oncol Biol Phys, 2004, 59(4) :1236-1244.
  • 4Lohr F, Dobler B, Mai S, et al. Optimization of dose distributions for adjuvant locoregional radiotherapy of gastric cancer by IMRT[J]. StrahlentherOnkol, 2003, 179(8):557-563.
  • 5Burman C, Kutcer G J, Emami B, et al. Fitting of normal tissue tolerance data to an analytic function[J]. Int J Radiat Oncol Biol Phys, 1991, 21(1): 123-135.
  • 6Macdonald J S, Smalley S R, Benedetti J, et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction[J]. N Engl J med, 2001, 345(10): 725-730.
  • 7Kim S, Lim D H, Lee J, et al. An observational study suggesting clinical benefit for adjuvant postoperative chemoradiation in a population of over 500 cases after gastric resection with D2 nodal dissection for adenocareinoma of the stomach[J]. Int J Radiat Oncol Biol Phys, 2005, 63(5):1279-1285.
  • 8Ringash J, Khaksar S, Oza A, et al. Post-operative radiochemotherapy for gastric cancer: Adoption and adaptation[J]. Clin Oncol, 2005, 17(2):91-95.
  • 9Cohen E P, Robbins M E. Radiation nephropathy[J]. Semin Nephrol, 2003, 23(5) :486-499.
  • 10Knab B, Rash C, Farrey K, et al. Intensity-modulated radiotherapy for neoadiuvant treatment of gastric cancer[J]. Med do sim, 2006, 31(4):292-297.

共引文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部